Lenz & Staehelin advised SQ Innovation, a life-science company specialised in the treatment of worsening heart failure, throughout closing of its Series B financing round. Newly-appointed member of the company’s supervisory board Marco van
Lenz & Staehelin advised SQ Innovation, a life-science company specialised in the treatment of worsening heart failure, throughout closing of its Series B financing round. Newly-appointed member of the company’s supervisory board Marco van